Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of the business’s stock in a transaction on Monday, August 14th. The shares were sold at an average price of $50.19, for a total transaction of $5,019,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, August 16th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $49.71, for a total transaction of $4,971,000.00.
  • On Wednesday, August 9th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.20, for a total transaction of $2,560,000.00.
  • On Thursday, August 10th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $50.84, for a total transaction of $5,084,000.00.
  • On Monday, August 7th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.26, for a total transaction of $2,563,000.00.
  • On Tuesday, August 8th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.13, for a total transaction of $5,113,000.00.
  • On Friday, August 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.13, for a total transaction of $5,113,000.00.
  • On Wednesday, August 2nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $52.03, for a total transaction of $5,203,000.00.
  • On Monday, July 31st, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $52.22, for a total transaction of $5,222,000.00.

Shares of Dolby Laboratories (NYSE:DLB) opened at 48.68 on Friday. The company has a market capitalization of $4.99 billion, a PE ratio of 24.90 and a beta of 0.79. The firm’s 50-day moving average price is $51.24 and its 200 day moving average price is $50.75. Dolby Laboratories has a one year low of $44.99 and a one year high of $55.02.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Tuesday, July 25th. The electronics maker reported $0.75 EPS for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.10. Dolby Laboratories had a return on equity of 10.25% and a net margin of 19.02%. The firm had revenue of $305.67 million for the quarter, compared to analyst estimates of $296.88 million. During the same period last year, the firm posted $0.62 earnings per share. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. Analysts anticipate that Dolby Laboratories will post $1.99 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Monday, August 7th were paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date of this dividend was Thursday, August 3rd. Dolby Laboratories’s payout ratio is 28.57%.

ILLEGAL ACTIVITY WARNING: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/08/18/dolby-laboratories-dlb-major-shareholder-sells-5019000-00-in-stock.html.

Several hedge funds have recently made changes to their positions in the stock. Alps Advisors Inc. raised its stake in shares of Dolby Laboratories by 0.3% in the second quarter. Alps Advisors Inc. now owns 9,461 shares of the electronics maker’s stock worth $463,000 after buying an additional 24 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of Dolby Laboratories by 0.4% in the first quarter. Ameriprise Financial Inc. now owns 15,650 shares of the electronics maker’s stock worth $821,000 after buying an additional 61 shares during the period. Envestnet Asset Management Inc. increased its position in shares of Dolby Laboratories by 0.3% in the first quarter. Envestnet Asset Management Inc. now owns 19,670 shares of the electronics maker’s stock worth $1,031,000 after buying an additional 66 shares during the period. US Bancorp DE increased its position in shares of Dolby Laboratories by 2.6% in the second quarter. US Bancorp DE now owns 3,029 shares of the electronics maker’s stock worth $149,000 after buying an additional 78 shares during the period. Finally, Raymond James Financial Services Advisors Inc. increased its position in shares of Dolby Laboratories by 1.2% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 7,769 shares of the electronics maker’s stock worth $380,000 after buying an additional 94 shares during the period. 50.38% of the stock is currently owned by hedge funds and other institutional investors.

DLB has been the topic of several recent analyst reports. B. Riley restated a “neutral” rating and issued a $57.00 target price (up previously from $52.00) on shares of Dolby Laboratories in a research note on Tuesday, April 25th. Zacks Investment Research raised Dolby Laboratories from a “hold” rating to a “buy” rating and set a $59.00 price target for the company in a report on Friday, April 28th. Finally, BidaskClub cut Dolby Laboratories from a “hold” rating to a “sell” rating in a report on Saturday, June 10th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $54.38.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Stock Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related stocks with our FREE daily email newsletter.